Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.32 |
| ▸ | PGD | P52209 | 2/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP3 | P08254 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | PDE4A | P27815 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7773086 | 0.83 | TSHR (0.42) | TSHRTP53PGDMMP1MMP2 | |
| SCHEMBL15512566 | 0.82 | TSHR (0.40) | TSHRTP53PGDHTT | |
| SCHEMBL4927159 | 0.81 | MAPT (0.38) | TSHRMAPTTP53FAAH | |
| SCHEMBL7778414 | 0.81 | MAPT (0.42) | TSHRMAPTTP53FAAHMMP1 | |
| SCHEMBL2554203 | 0.80 | TSHR (0.39) | TSHRTP53PGDMMP1MMP2 | |
| SCHEMBL2554204 | 0.80 | TSHR (0.39) | TSHRTP53PGDMMP1MMP2 | |
| SCHEMBL26073594 | 0.80 | MGAM (0.38) | TSHRMMP1MMP2MMP3MMP9 | |
| Cadaverine Tartrate SCHEMBL30599689 | 0.80 | MGAM (0.38) | TSHRMMP1MMP2MMP3MMP9 | |
| SCHEMBL3205518 | 0.79 | PRKCA (0.41) | TSHR | |
| SCHEMBL334795 | 0.78 | MAPT (0.44) | TSHRMAPTTP53FAAHMMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 638 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1146402-C | Gel compositions and methods | — | 2004-04-21 | — | — | CN | claimed |
| US-6045785-A | COMPRISING A STEROL SULFATE, ALUMINUM CHLOROHYDRATE, AND AN ESTERASE INHIBITOR, A BACTERICIDAL AGENT, OR A BACTERIOSTATIC AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-04-04 | — | — | US | claimed |
| CN-1240346-A | Injectable depot gel composition and method of preparing the composition | ALZA CORP (US) | 2000-01-05 | — | — | CN | claimed |
| EP-4731617-A1 | USE OF DIHYDROPYRAN DERIVATIVES AS AROMA CHEMICALS | BASF SE (DE) | 2026-04-29 | — | — | EP | disclosed |
| EP-4728447-A1 | ENVIRONMENTAL ATTRIBUTES FOR AROMA CHEMICAL | BASF SE (DE) | 2026-04-22 | — | — | EP | disclosed |
| EP-4077299-B1 | SUBSTITUTED 4-METHYLENE-TETRAHYDROPYRANS, 4-METHYL-DIHYDROPYRANS AND 4-METHYL-TETRAHYDROPYRANS AND USE THEREOF AS AROMA CHEMICALS | BASF SE (DE) | 2026-04-01 | — | — | EP | disclosed |
| EP-4716732-A1 | USE OF ALKYL 4-ALKOXYPENTANOATES AS AROMA CHEMICALS | BASF SE (DE) | 2026-04-01 | — | — | EP | disclosed |
| US-12551420-B2 | 1-alkoxyethyl-3-isobutyl-benzene and 1-carboxyethyl-3-isobutyl-benzene as aroma ingredients | BASF SE (DE) | 2026-02-17 | — | — | US | disclosed |
| US-12492355-B2 | 2,4-diethylocta-2,6-dienal and its use as aroma chemical | BASF SE (DE) | 2025-12-09 | — | — | US | disclosed |
| US-20250368600-A1 | USE OF CYCLOHOMOGERANATE ESTERS AS AROMA CHEMICALS | BASF SE (DE) | 2025-12-04 | — | — | US | disclosed |
| US-12467014-B2 | Dodecandien-1-ol and dodecen-1-ol or mixtures thereof as aroma chemicals | BASF SE (DE) | 2025-11-11 | — | — | US | disclosed |
| US-6368577-B1 | FOR COSMETICS, DRUGS | COGNIS DEUTSCHLAND GMBH (DE) | 2002-04-09 | — | — | US | disclosed |
| US-20020010114-A1 | Water-based cleansing compositions | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2002-01-24 | — | — | US | disclosed |
| US-6316030-B1 | ABSORPTION, IN COSMETICS AND DRUGS | COGNIS DEUTSCHLAND GMBH (DE) | 2001-11-13 | — | — | US | disclosed |
| US-6277359-B1 | (A) A GEMINI SURFACTANT OF A DIMER OR TRIMER ALCOHOL SULFATE; (B) ALUMINUM CHLOROHYDRATE; AND (C) AN ESTERASE INHIBITOR, A BACTERICIDAL AGENT, OR A BACTERIOSTATIC AGENT | COGNIS DEUTSCHLAND GMBH (DE) | 2001-08-21 | — | — | US | disclosed |
| US-6045785-A | COMPRISING A STEROL SULFATE, ALUMINUM CHLOROHYDRATE, AND AN ESTERASE INHIBITOR, A BACTERICIDAL AGENT, OR A BACTERIOSTATIC AGENT | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2000-04-04 | — | — | US | disclosed |
| CN-1240346-A | Injectable depot gel composition and method of preparing the composition | ALZA CORP (US) | 2000-01-05 | — | — | CN | disclosed |
| US-5968488-A | SKIN SENSITIVITY; ANTIPERSPIRANTS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1999-10-19 | — | — | US | disclosed |
| US-4224026-A | Process for preparing fast dyeings and prints on cellulose fiber materials and their mixtures with synthetic fibers | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-09-23 | — | — | US | disclosed |
| US-4101323-A | Radiation-sensitive copying composition | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12551420-B2 | 1-alkoxyethyl-3-isobutyl-benzene and 1-carboxyethyl-3-isobutyl-benzene as aroma ingredients | EBP, OR10J3, ADRA1D | TSHR 3102/4885MAPT 2348/4885TP53 3290/4885 |
| US-20020010114-A1 | Water-based cleansing compositions | LIPA, WASHC4, WASHC5 | TSHR 3016/4885MAPT 2657/4885TP53 1901/4885 |
| US-20250368600-A1 | USE OF CYCLOHOMOGERANATE ESTERS AS AROMA CHEMICALS | DECR1, TECR, AKR1C2 | TSHR 1121/4885MAPT 1253/4885TP53 4860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.